Biomea Fusion, Inc. cash flow to debt ratio of -4.43K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Biomea Fusion, Inc.'s free cash flow has increased -41.48% from $-120.26M last year to $-70.37M, signaling increasing performance

Biomea Fusion, Inc.'s debt to equity ratio is 0.07, which means that the company's assets are healthy financed, signaling financial stability.

Biomea Fusion, Inc.'s debt has decreased relative to shareholder equity from 0.17 last year to 0.07 today, signaling strengthened financials

Biomea Fusion, Inc. has a net cash position, so leverage is healthy.

Biomea Fusion, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Biomea Fusion, Inc. has insufficient data to evaluate this check.

Biomea Fusion, Inc.'s short-term assets of $58.05M exceed its short-term liabilities of $11.10M

Biomea Fusion, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Biomea Fusion, Inc.'s return on equity of -171.19%, is lower than 15.00%, indicating bad performance

Biomea Fusion, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Biomea Fusion, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Biomea Fusion, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Biomea Fusion, Inc. has negative free cash flow, indicating cash burn

Biomea Fusion, Inc.'s yearly earnings has increased -55.36% since last year from $-138.43M to $-61.80M, signaling increasing performance

Biomea Fusion, Inc.'s yearly revenue has increased 0.00% since last year from $0.00 to $0.00, signaling increasing performance

ROIC -212.95% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Biomea Fusion, Inc. has insufficient revenue history to calculate 3-year revenue CAGR.

Biomea Fusion, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Biomea Fusion, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Biomea Fusion, Inc. has insufficient data to evaluate this check.

Biomea Fusion, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Biomea Fusion, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Biomea Fusion, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Biomea Fusion, Inc. has insufficient data to evaluate this check.

Biomea Fusion, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Biomea Fusion, Inc. has a price-to-book ratio of 7.57x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Biomea Fusion, Inc. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue